CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
80 hedge funds and large institutions have $227M invested in Concert Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 17 reducing their positions, and 9 closing their positions.
Holders
80
Holders Change
+10
Holders Change %
+14.29%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
33
Reduced
17
Closed
9
Calls
$1.12M
Puts
$105K
Net Calls
+$1.01M
Net Calls Change
+$464K
Top Buyers
1 |
TCM
1
Tang Capital Management
San Diego,
California
|
$6.72M |
2 |
KCM
2
Kynam Capital Management
Princeton,
New Jersey
|
$11.2M |
3 |
AG
3
Artal Group
Luxembourg
|
$3.84M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$7.51M |
5 |
5
BlackRock
New York
|
$5.54M |